KARA KIREYCZYK: Open Payments
NPI 1457684862 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 26 payments from 12 companies in 2025. Trend: 2023 $978 · 2024 $834 · 2025 $839
Food & beverage: $839
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 4 | $170 |
| Madrigal Pharmaceuticals | 1 | $150 |
| ABBVIE INC. | 6 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $127 |
| Gilead Sciences, Inc. | 3 | $65 |
| Fujifilm Healthcare Americas Corporation | 2 | $61 |
| Phathom Pharmaceuticals, Inc. | 1 | $33 |
| Novo Nordisk Inc | 1 | $29 |
| Janssen Biotech, Inc. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
Products named: Sucraid, REZDIFFRA, ENTYVIO, UTASWAKO AFP-L3, GATTEX, RINVOQ, LINZESS, SKYRIZI.
Industry payments across CT — which companies pay providers there.
